The Ministry of Health (MOH), through the Department of Pharmaceuticals and Natural Medicines (DPNM), executed the national integrated quantification for all Essential Medicines and Health Supplies (EMHS) for the financial year 2024/25.�As a result, the total commodity need for routine service deliv...
The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 14 to 18 October 2013. Dr M.-P. Kieny, Assistant Director-General of Health Systems and Innovation at the World Health Organization (WHO), welcomed participants on behalf of the Director-General. Dr Kieny t...
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decision making . This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate...
Problems related to the safety and quality of drugs exist in many places around the world today, in developing and developed countries alike. Some incidents have ended in tragedy, often with children as the victims. They are caused by the use of drugs containing toxic substances or impurities, drugs...
The thirty-ninth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 6 to 10 November 2017. Dr Suzanne Hill, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting by welcoming all par...
This manual represents the revised and updated edition of the Essential Medicines and Health Supplies�(EMHS) Management Manual, following its initial publication in 2012. The Department of�Pharmaceuticals and Natural Medicines (DPNM) of the Ministry of Health, in collaboration with�development partn...
The Fifty-third meeting of the World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) took place in Geneva, Switzerland, from 22 to 26 October 2018. Participants of the meeting were welcomed by Dr Mariângela Simão, Assistant Director-General, Acces...
Drug use, drug use disorders and related health conditions are major public health concerns. According to WHO��s latest estimates for 2015, psychoactive drug use is responsible for more than 450 000 deaths per year. The drug-attributable disease burden accounts for about 1.5% of the global burden of...
The Essential Medicines and Health Supplies List for�Uganda (EMHSLU) 2023 reflects the policy of the�Ministry of Health, for the appropriate procurement�of safe and efficacious essential medicines, health and�laboratory supplies in public institutions.�The EMHSLU 2023 was compiled based on�recommend...
About 275 million people worldwide, which is roughly 5.6 per cent of the global population aged 15-64 years, used drugs at least once during 2016. Some 31 million of people who use drugs suffer from drug use disorders, meaning that their drug use is harmful to the point where they may need treatment...
The thirty-seventh meeting of the WHO Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 16 to 20 November 2015. Mr Cornelis de Joncheere, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. He welcomed all participants on beh...
A standard operating procedure (SOP) is a set of systematic instructions compiled by an organization to help workers carry out complex routine operations. SOPs aim to achieve efficiency, quality output and uniformity of performance, while reducing miscommunication and failure to comply with regulati...
The schedue provides for control of 98 psychotropical substances which are assigned to one of the four schedues.
The Ministry of Health (MOH), in collaboration with the U.S. Agency for International Development (USAID), the Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund), the USAID Global Health Supply Chain-Procurement and Supply Management (GHSC-PSM) project, and the USAID Uganda Health...
The National Drug Authority Strategic Plan 2020/2021-2024/2025 builds on the gains achieved in the previous period and also focuses on consolidating efficiency and effectiveness in drug regulation, as provided for within the mandate of the Drug Authority. This strategic plan has been aligned to the...
The Ministry of Health (MoH) Department of Pharmaceuticals and Natural Medicines (DPNM) coordinated the first integrated quantification process for Essential Medicines and Health Supplies (EMHS) for the public and PNFP sector for Financial Years 2023/24 - 2025/26.�Quantification is a core component...
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decision making. This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate s...
The third National Pharmaceutical Sector Strategic Plan 2015/16-2019/20 (NPSSP III) has been developed to support the implementation of the National Medicines Policy (NMP) 2015. The NPSSP III was developed through wide consultations with diverse stakeholders including representatives from the privat...
The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 14 to 18 October 2013. Dr M.-P. Kieny, Assistant Director- General of Health Systems and Innovation at the World Health Organization (WHO), welcomed participants on behalf of the Director-General. Dr Kieny...
This report provides feedback on the FY2017/18 national quantification, an annual exercise conducted by NMS together with MoH and all government Health Facilities (HFs) and aimed to inform accurate planning for the supply of EMHLS in the public sector.
